These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7692559)

  • 1. Non-specific activity of (+/-)CP-96,345 in models of pain and inflammation.
    Nagahisa A; Asai R; Kanai Y; Murase A; Tsuchiya-Nakagaki M; Nakagaki T; Shieh TC; Taniguchi K
    Regul Pept; 1993 Jul; 46(1-2):433-6. PubMed ID: 7692559
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of intrathecally injected glutamate and substance P antagonists on repeated cold stress-induced hyperalgesia in rats.
    Okano K; Kuraishi Y; Satoh M
    Biol Pharm Bull; 1995 Jan; 18(1):42-4. PubMed ID: 7537576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of spinal substance P and excitatory amino acids in inflammatory hyperalgesia in rats.
    Okano K; Kuraishi Y; Satoh M
    Jpn J Pharmacol; 1998 Jan; 76(1):15-22. PubMed ID: 9517400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the nonpeptide NK-1 receptor antagonist CP-96,345 on the morphine withdrawal response of guinea-pigs.
    Chahl LA; Johnston PA
    Regul Pept; 1993 Jul; 46(1-2):373-5. PubMed ID: 7692540
    [No Abstract]   [Full Text] [Related]  

  • 5. Non-specific activity of (+/-)-CP-96,345 in models of pain and inflammation.
    Nagahisa A; Asai R; Kanai Y; Murase A; Tsuchiya-Nakagaki M; Nakagaki T; Shieh TC; Taniguchi K
    Br J Pharmacol; 1992 Oct; 107(2):273-5. PubMed ID: 1330170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SR 48968 specifically depresses neurokinin A- vs. substance P-induced hyperalgesia in a nociceptive withdrawal reflex.
    Yashpal K; Hui-Chan CW; Henry JL
    Eur J Pharmacol; 1996 Jul; 308(1):41-8. PubMed ID: 8836630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of NK-1 receptor in central cardiovascular regulation in rats: studies on a novel non-peptide antagonist, CP-96,345, of substance P NK-1 receptor.
    Saigo A; Takano Y; Saito R; Nakayama Y; Honda K; Kamiya H
    Regul Pept; 1993 Jul; 46(1-2):293-6. PubMed ID: 7692520
    [No Abstract]   [Full Text] [Related]  

  • 8. Ventilatory responses to hypoxia in rats pretreated with nonpeptide NK1 receptor antagonist CP-96,345.
    De Sanctis GT; Green FH; Jiang X; King M; Remmers JE
    J Appl Physiol (1985); 1994 Apr; 76(4):1528-32. PubMed ID: 7519186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the selective non-peptide NK-1 receptor antagonist CP96,345 a peripherally acting analgesic?
    Berge OG; Ståhlberg M
    Regul Pept; 1993 Jul; 46(1-2):430-2. PubMed ID: 7692558
    [No Abstract]   [Full Text] [Related]  

  • 10. Receptor characterization of the spinal action of neurokinins on nociception: a three receptor hypothesis.
    Couture R; Boucher S; Picard P; Regoli D
    Regul Pept; 1993 Jul; 46(1-2):426-9. PubMed ID: 7692557
    [No Abstract]   [Full Text] [Related]  

  • 11. Antiinflammatory and analgesic activity of CP-96,345: an orally active non-peptide substance P receptor antagonist.
    Nagahisa A; Kanai Y; Suga O; Taniguchi K; Tsuchiya M; Lowe JA; Hess HJ
    Regul Pept; 1993 Jul; 46(1-2):440-3. PubMed ID: 7692561
    [No Abstract]   [Full Text] [Related]  

  • 12. Two related neurokinin-1 receptor antagonists have overlapping but different binding sites.
    Greenfeder S; Cheewatrakoolpong B; Anthes J; Billah M; Egan RW; Brown JE; Murgolo NJ
    Bioorg Med Chem; 1998 Feb; 6(2):189-94. PubMed ID: 9547942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective blockade of sensory response of the carotid body to hypoxia by NK-1 receptor antagonist CP-96,345.
    Prabhakar NR; Snider RM; Lowe JA; Cao H
    Regul Pept; 1993 Jul; 46(1-2):266-8. PubMed ID: 7692512
    [No Abstract]   [Full Text] [Related]  

  • 14. [Preparation and characteristics of a tritiated derivative of CP-96,345--a nonpeptide antagonist of the substance P receptor with a high specific radioactivity].
    Kasheverov IE; Zaĭtsev DA; Utkin IuN; Tsetlin VI
    Bioorg Khim; 1994 Nov; 20(11):1162-8. PubMed ID: 7880176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different behavioral profiles of the non-peptide substance P (NK-1) antagonists CP-96,345 and RP 67580.
    Saria A; Troger J; Zernig G
    Regul Pept; 1993 Jul; 46(1-2):346-8. PubMed ID: 7692533
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of FK224, a novel cyclopeptide NK1 and NK2 antagonist, and CP-96,345, a nonpeptide NK1 antagonist, on development and maintenance of thermal hyperesthesia evoked by carrageenan injection in the rat paw.
    Yamamoto T; Shimoyama N; Mizuguchi T
    Anesthesiology; 1993 Nov; 79(5):1042-50. PubMed ID: 7694526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of CP-96,345 a non-peptide substance P antagonist, capsaicin, resiniferatoxin and ruthenium red on nociception.
    Szolcsányi J; Nagy J; Pethö G
    Regul Pept; 1993 Jul; 46(1-2):437-9. PubMed ID: 7692560
    [No Abstract]   [Full Text] [Related]  

  • 18. Mediation by bradykinin of rat paw oedema induced by collagenase from Clostridium histolyticum.
    Legat FJ; Griesbacher T; Lembeck F
    Br J Pharmacol; 1994 Jun; 112(2):453-60. PubMed ID: 7915609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Participation of substance P in spinal physiological responses to peripheral aversive stimulation.
    Henry JL
    Regul Pept; 1993 Jul; 46(1-2):138-43. PubMed ID: 7692482
    [No Abstract]   [Full Text] [Related]  

  • 20. Involvement of substance P and neurokinin-1 receptors in the hyperexcitability of dorsal horn neurons during development of acute arthritis in rat's knee joint.
    Neugebauer V; Weiretter F; Schaible HG
    J Neurophysiol; 1995 Apr; 73(4):1574-83. PubMed ID: 7643168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.